Dow Up 1.31% Nasdaq Up 2.40%

Alkermes plc (ALKS)

-NasdaqGS
43.80 0.63(1.46%) Oct 21, 4:00PM EDT
Prev Close:43.17
Open:43.78
Bid:42.02 x 200
Ask:N/A
1y Target Est:50.92
Beta:1.71
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:43.14 - 44.18
52wk Range:34.28 - 54.25
Volume:758,914
Avg Vol (3m):856,712
Market Cap:6.39B
P/E (ttm):N/A
EPS (ttm):-0.05
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALKS

Comparison

Symbol% ChgMkt Cap
ALKSUp 1.46%6.39B
ABT63.74B
LLY69.32B
GSK104.80B

Key Statistics

Forward P/E (1 yr):76.84
P/S (ttm):11.27
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.27
Quarterly EPS Est (Sep-14) :0.02
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):5.63

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alkermes Public Limited Company, an integrated biopharmaceutical company, develops medicines that enhance patient outcomes. The company offers RISPERDAL CONSTA for schizophrenia and bipolar I disorder; INVEGA SUSTENNA to treat schizophrenia; AMPYR... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback